Other
Obstructive Jaundice
5
Pipeline Programs↗
1
Active Trials↗
5
Companies Involved↗
Obstructive Jaundice is an early-stage landscape with 5 programs across 5 companies. The most active players are Validus Pharmaceuticals, Daewoong Pharmaceutical Co. LTD., AbbVie. 1 therapy is approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical2
Phase 1
No programs
Phase 3
No programs
Approved1
Analysis
Trial Status
4
clinical trials
Unknown status2 · 50%
Completed1 · 25%
Recruiting1 · 25%
Clinical Trials
Trial Activity
Effect of Methylene Blue on Perioperative Organ Function in Patients With Obstructive Jaundice
Unknown status·—·Phase 1·NCT04109859·64 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)